-
Healthy Habits
Inflammation ConnectionCould a diet that leads to inflammation increase the risk of developing colorectal cancer?
by Lindsey Konkel
-
Healthy Habits
Small StridesExercise is associated with benefits, even for those who fall short of recommended amounts.
by Jane C. Hu
-
Forward Look
By the NumbersTalking to doctors about cancer and its treatment often means being bombarded with numbers, from percentages to risk ratios. Yet many people don’t fully comprehend what the numbers mean. As a result, cancer patients may not understand their prognosis, the effect a treatment might have, or their risk for recurrence. Photo © iStock / PeterHermesFurian To […]
by Cameron Walker
-
Forward Look
The Evolution of CancerQ&A with molecular biologist James DeGregori on cancer development.
by Sue Rochman
-
Forward Look
Breast Density MattersBreast cancer risk factor may be overlooked.
by Kendall K. Morgan
-
Forward Look
More Options for Adolescents in Clinical TrialsNew recommendations support inclusion of teens in adult studies.
by Susan Kreimer
-
Forward Look
Choosing a Cancer CenterNCI-designated cancer centers play an important role in patient care.
by Kristine Meldrum Denholm
-
Forward Look
The Cost of PrescriptionsFinancial factors can influence cancer patients' use of medications
by Kate Yandell
-
Forward Look
Tackling Drug ResistanceResearchers are studing new ways to keep treatments working longer.
by Stephen Ornes
-
A New Look for Clinical Trials
More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
Cancer Talk
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons